This HTML5 document contains 238 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dbthttp://dbpedia.org/resource/Template:
n30https://www.ipsen.com/en/
wikipedia-enhttp://en.wikipedia.org/wiki/
dbrhttp://dbpedia.org/resource/
dbpedia-mshttp://ms.dbpedia.org/resource/
n37http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
n18http://viaf.org/viaf/
schemahttp://schema.org/
n32https://
n15http://commons.wikimedia.org/wiki/Special:FilePath/
dbpedia-frhttp://fr.dbpedia.org/resource/
skoshttp://www.w3.org/2004/02/skos/core#
dctermshttp://purl.org/dc/terms/
rdfshttp://www.w3.org/2000/01/rdf-schema#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n28http://d-nb.info/gnd/
dbphttp://dbpedia.org/property/
n12http://www.grid.ac/institutes/
xsdhhttp://www.w3.org/2001/XMLSchema#
dbpedia-idhttp://id.dbpedia.org/resource/
dbohttp://dbpedia.org/ontology/
dbpedia-pthttp://pt.dbpedia.org/resource/
dbpedia-jahttp://ja.dbpedia.org/resource/
dbchttp://dbpedia.org/resource/Category:
dbpedia-dehttp://de.dbpedia.org/resource/
dbpedia-thhttp://th.dbpedia.org/resource/
yagohttp://dbpedia.org/class/yago/
dbpedia-ruhttp://ru.dbpedia.org/resource/
wikidatahttp://www.wikidata.org/entity/
yago-reshttp://yago-knowledge.org/resource/
n24https://global.dbpedia.org/id/
dbpedia-ithttp://it.dbpedia.org/resource/
provhttp://www.w3.org/ns/prov#
foafhttp://xmlns.com/foaf/0.1/
dbpedia-fahttp://fa.dbpedia.org/resource/
n27http://www.w3.org/2006/03/wn/wn20/instances/
dbpedia-eshttp://es.dbpedia.org/resource/
freebasehttp://rdf.freebase.com/ns/
owlhttp://www.w3.org/2002/07/owl#

Statements

Subject Item
dbr:Cabozantinib
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Roy_Walford
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Merrimack_Pharmaceuticals
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Botulinum_toxin
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:David_Meek
dbo:wikiPageWikiLink
dbr:Ipsen
dbp:office
dbr:Ipsen
Subject Item
dbr:Huda_Zoghbi
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Innovative_Medicines_Canada
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:List_of_largest_French_companies
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:List_of_pharmaceutical_companies
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:List_of_pharmaceutical_manufacturers_in_the_United_Kingdom
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Salk_Institute_for_Biological_Studies
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:National_Organization_for_Rare_Disorders
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Cicletanine
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Galderma
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Gerald_E._McClearn
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Anne_Beaufour
dbo:wikiPageWikiLink
dbr:Ipsen
dbp:boards
dbr:Ipsen
dbo:board
dbr:Ipsen
Subject Item
dbr:Pharma_Documentation_Ring
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Pharmaceutical_Research_and_Manufacturers_of_America
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Marc_de_Garidel
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:BIOTECanada
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Cathy_Price
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Trevor_Robbins
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Triptorelin
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:GTx_Incorporated
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Ipsen
rdf:type
yago:Company108058098 yago:YagoPermanentlyLocatedEntity yago:YagoLegalActor yago:YagoLegalActorGeo yago:WikicatCompaniesBasedInParis owl:Thing dbo:Company yago:WikicatPharmaceuticalCompaniesEstablishedIn1929 wikidata:Q4830453 wikidata:Q43229 yago:Abstraction100002137 wikidata:Q24229398 yago:WikicatPharmaceuticalCompanies yago:Institution108053576 yago:Group100031264 yago:SocialGroup107950920 yago:DrugCompany108002578 yago:WikicatCompaniesEstablishedIn1929 yago:WikicatPharmaceuticalCompaniesOfFrance yago:WikicatPharmaceuticalCompaniesOfTheUnitedKingdom yago:Organization108008335 schema:Organization dbo:Agent n37:SocialPerson dbo:Organisation n37:Agent
rdfs:label
イプセン (製薬会社) Ipsen Ipsen Ipsen Ipsen Ipsen Ipsen Ipsen Ipsen Group
rdfs:comment
イプセン（フランス語: Ipsen S.A.）は、フランス・パリに本社を置き、世界20カ国以上に拠点を持つ製薬企業である。主に腫瘍、内分泌、神経筋障害の処置に使用される薬品を開発し販売している。ユーロネクスト・パリに上場している。 Ipsen — французская фармацевтическая компания. Штаб-квартира расположена в Булонь-Бийанкур (пригород Парижа, Франция). Специализируется на трех терапевтических областях: онкология, нейробиология и редкие заболевания. Компания продает более 20 лекарств в 115 странах. Семья Бофур, которая занимает 42-е место среди самых богатых семей Франции, по-прежнему владеет 57 % акций и 73 % голосов, а два её члена (внуки основателя Анн Бофур и Анри Бофур) являются членами совета директоров. Ipsen è una società farmaceutica francese con sede a Parigi, Francia. È specializzato in tre aree terapeutiche: oncologia, neuroscienze e malattie rare. È quotato in borsa su Euronext Paris come parte dell'indice SBF 120 (2005). Ipsen, fondata da Henri Beaufour nel 1929, ha più di 5.700 dipendenti in tutto il mondo e commercializza più di 20 farmaci in 115 paesi. Ipsen est un groupe biopharmaceutique français fondé en 1929, spécialisé en oncologie, en neurosciences, dans les maladies rares, ainsi qu'en santé familiale. L'entreprise réalise un chiffre d’affaires de 2,6 milliards d’euros (2019) et commercialise une vingtaine de médicaments dans 115 pays. Il réunit plus de 5 700 salariés dans le monde. IPSEN est l'acronyme de « Institut des produits de synthèse et d'extraction naturelle ». Les activités actuelles du groupe sont davantage diversifiées qu'à l'origine. Ipsen é uma empresa farmacêutica francesa com sede em Paris, França. Fundamentalmente, desenvolve e comercializa medicamentos usados em oncologia, endocrinologia e no tratamento das doenças neuromusculares. A Ipsen atuava no mercado brasileiro por meio de parceiros distribuidores dos seus medicamentos, contudo, em 2009 a empresa decidiu abrir sua filial em São Paulo visando estreitar os lanços com seus clientes. Ipsen is a French pharmaceutical company headquartered in Paris, France. It is specialized in oncology, neuroscience and rare diseases. It is publicly traded on the Euronext Paris as part of the SBF 120 index (2005). Ipsen, founded by Henri Beaufour in 1929, has 5,700 employees worldwide, and markets 20 drugs in 115 countries. The Beaufour family owns 57% of its shares and 73% of its voting rights, and two of its members, Anne Beaufour and Henri Beaufour, sit on its board of directors. Ipsen es una empresa farmacéutica francesa con sede en París, Francia.​ Se especializa en tres áreas de terapia: oncología, neurociencia y enfermedades raras. Se cotiza en bolsa en Euronext Paris como parte del índice SBF 120 (2005). Ipsen, fundada por Henri Beaufour en 1929, tiene más de 5.700 empleados en todo el mundo y comercializa más de 20 medicamentos en 115 países.​ Ipsen Group ist ein global agierendes biopharmazeutisches Unternehmen. Das Unternehmen wurde 1929 in Dreux, Frankreich gegründet. Der heutige Firmensitz befindet sich in Paris. Der Deutschlandsitz in München. Das Unternehmen ist im Familienbesitz der Familie Beaufour und beschäftigt rund 4.000 Mitarbeiter. Zu den von Ipsen Group hergestellten Medikamenten gehören unter anderem in der Ipsen adalah perusahaan farmasi Prancis yang berbasis di Paris, Prancis. Perusahaan ini mengkhususkan diri dalam tiga bidang terapi: onkologi, ilmu saraf, dan penyakit langka. Ini diperdagangkan secara publik di Euronext Paris sebagai bagian dari indeks SBF 120 (2005). Ipsen, didirikan oleh Henri Beaufour pada tahun 1929, memiliki lebih dari 5.700 karyawan di seluruh dunia dan memasarkan lebih dari 20 obat di 115 negara.
foaf:name
Ipsen S.A.
foaf:homepage
n32:www.ipsen.com
dbp:name
Ipsen S.A.
foaf:depiction
n15:Ipsen_logo.svg
dbo:location
dbr:Paris
dcterms:subject
dbc:French_companies_established_in_1929 dbc:Pharmaceutical_companies_established_in_1929 dbc:Companies_listed_on_Euronext_Paris dbc:Manufacturing_companies_based_in_Paris dbc:Pharmaceutical_companies_of_France
dbo:wikiPageID
4937414
dbo:wikiPageRevisionID
1123865604
dbo:wikiPageWikiLink
dbr:European_Society_for_Medical_Oncology dbc:French_companies_established_in_1929 dbr:Gastroenterology dbc:Pharmaceutical_companies_established_in_1929 dbc:Companies_listed_on_Euronext_Paris dbr:European_Commission dbr:Anne_Beaufour dbr:University_of_Rennes_1 dbr:Milton_Park dbr:Galderma dbr:Pain dbr:Euronext_Paris dbr:United_Kingdom dbr:Multiple_sclerosis dbr:Paris dbr:Fondation_de_France dbr:Cognitive_disorder dbr:Diosmectite dbr:China dbr:Subsidiary dbr:Pharmaceutical dbr:Pharmaceutical_company dbr:Merrimack_Pharmaceuticals dbr:SBF_120 dbr:Massachusetts dbr:French_Alternative_Energies_and_Atomic_Energy_Commission dbr:Henri_Beaufour dbr:Indigestion dbr:Cough dbc:Manufacturing_companies_based_in_Paris dbr:Russia dbr:CAC_Mid_60 dbr:Rare_diseases dbr:Blood_vessel dbr:Dreux dbr:Research_and_development dbr:French_National_Centre_for_Scientific_Research dbr:Cabozantinib dbr:Irinotecan dbr:Oxford dbc:Pharmaceutical_companies_of_France dbr:United_States dbr:Oncology dbr:Cambridge,_Massachusetts dbr:Neuroscience dbr:Marc_de_Garidel
dbo:wikiPageExternalLink
n30: n32:www.ipsen.com
owl:sameAs
dbpedia-it:Ipsen yago-res:Ipsen dbpedia-de:Ipsen_Group dbpedia-th:อิปเซน dbpedia-pt:Ipsen dbpedia-es:Ipsen n24:BUg4 dbpedia-fr:Ipsen n28:4785808-4 dbpedia-ru:Ipsen wikidata:Q111546 freebase:m.025t90v n18:148436614 n28:2117601-2 dbpedia-ja:イプセン_(製薬会社) dbpedia-fa:ایپسن dbpedia-ms:Ipsen n18:236582255 dbpedia-id:Ipsen
dbp:wikiPageUsesTemplate
dbt:Reflist dbt:Use_dmy_dates dbt:CAC_Mid_60 dbt:Official dbt:Citation_needed dbt:Infobox_company dbt:About dbt:EngvarB dbt:Self-published_inline dbt:Authority_control
dbo:thumbnail
n15:Ipsen_logo.svg?width=300
dbp:certain
yes
dbp:date
July 2019
dbp:foundation
1929
dbp:homepage
n32:www.ipsen.com
dbp:industry
dbr:Pharmaceutical
dbp:keyPeople
dbr:Marc_de_Garidel David Loew
dbp:location
Paris, France
dbp:logo
Ipsen logo.svg
dbp:numEmployees
5700
dbp:products
*Targeted therapeutic areas : oncology, neuroscience and rare diseases *Consumer healthcare: gastroenterology, cognitive disorders, pain, cough and cold
dbp:tradedAs
Euronext:IPN dbr:CAC_Mid_60
dbp:type
Public
dbo:abstract
Ipsen Group ist ein global agierendes biopharmazeutisches Unternehmen. Das Unternehmen wurde 1929 in Dreux, Frankreich gegründet. Der heutige Firmensitz befindet sich in Paris. Der Deutschlandsitz in München. Das Unternehmen ist im Familienbesitz der Familie Beaufour und beschäftigt rund 4.000 Mitarbeiter. Zu den von Ipsen Group hergestellten Medikamenten gehören unter anderem in der * Onkologie – Cabometyx und Cometriq (Cabozantinib), Decapeptyl * Endokrinologie – Somatuline (Lanretoid, ein Somatostatin-Analogon), NutropinAq (Somatropin), Testim (Testosteron-Gel) * neuromuskularen Störungen – Dysport (Botulinumtoxin A). Ipsen é uma empresa farmacêutica francesa com sede em Paris, França. Fundamentalmente, desenvolve e comercializa medicamentos usados em oncologia, endocrinologia e no tratamento das doenças neuromusculares. A Ipsen atuava no mercado brasileiro por meio de parceiros distribuidores dos seus medicamentos, contudo, em 2009 a empresa decidiu abrir sua filial em São Paulo visando estreitar os lanços com seus clientes. Ipsen adalah perusahaan farmasi Prancis yang berbasis di Paris, Prancis. Perusahaan ini mengkhususkan diri dalam tiga bidang terapi: onkologi, ilmu saraf, dan penyakit langka. Ini diperdagangkan secara publik di Euronext Paris sebagai bagian dari indeks SBF 120 (2005). Ipsen, didirikan oleh Henri Beaufour pada tahun 1929, memiliki lebih dari 5.700 karyawan di seluruh dunia dan memasarkan lebih dari 20 obat di 115 negara. Ipsen is a French pharmaceutical company headquartered in Paris, France. It is specialized in oncology, neuroscience and rare diseases. It is publicly traded on the Euronext Paris as part of the SBF 120 index (2005). Ipsen, founded by Henri Beaufour in 1929, has 5,700 employees worldwide, and markets 20 drugs in 115 countries. The Beaufour family owns 57% of its shares and 73% of its voting rights, and two of its members, Anne Beaufour and Henri Beaufour, sit on its board of directors. Ipsen es una empresa farmacéutica francesa con sede en París, Francia.​ Se especializa en tres áreas de terapia: oncología, neurociencia y enfermedades raras. Se cotiza en bolsa en Euronext Paris como parte del índice SBF 120 (2005). Ipsen, fundada por Henri Beaufour en 1929, tiene más de 5.700 empleados en todo el mundo y comercializa más de 20 medicamentos en 115 países.​ Ipsen è una società farmaceutica francese con sede a Parigi, Francia. È specializzato in tre aree terapeutiche: oncologia, neuroscienze e malattie rare. È quotato in borsa su Euronext Paris come parte dell'indice SBF 120 (2005). Ipsen, fondata da Henri Beaufour nel 1929, ha più di 5.700 dipendenti in tutto il mondo e commercializza più di 20 farmaci in 115 paesi. Ipsen — французская фармацевтическая компания. Штаб-квартира расположена в Булонь-Бийанкур (пригород Парижа, Франция). Специализируется на трех терапевтических областях: онкология, нейробиология и редкие заболевания. Компания продает более 20 лекарств в 115 странах. Семья Бофур, которая занимает 42-е место среди самых богатых семей Франции, по-прежнему владеет 57 % акций и 73 % голосов, а два её члена (внуки основателя Анн Бофур и Анри Бофур) являются членами совета директоров. Ipsen est un groupe biopharmaceutique français fondé en 1929, spécialisé en oncologie, en neurosciences, dans les maladies rares, ainsi qu'en santé familiale. L'entreprise réalise un chiffre d’affaires de 2,6 milliards d’euros (2019) et commercialise une vingtaine de médicaments dans 115 pays. Il réunit plus de 5 700 salariés dans le monde. IPSEN est l'acronyme de « Institut des produits de synthèse et d'extraction naturelle ». Les activités actuelles du groupe sont davantage diversifiées qu'à l'origine. イプセン（フランス語: Ipsen S.A.）は、フランス・パリに本社を置き、世界20カ国以上に拠点を持つ製薬企業である。主に腫瘍、内分泌、神経筋障害の処置に使用される薬品を開発し販売している。ユーロネクスト・パリに上場している。
schema:sameAs
n18:236582255
dbp:wordnet_type
n27:synset-company-noun-1
skos:closeMatch
n12:grid.438365.f n12:grid.473168.f n12:grid.476482.b n12:grid.476480.9 n12:grid.476474.2 n12:grid.476475.3
prov:wasDerivedFrom
wikipedia-en:Ipsen?oldid=1123865604&ns=0
dbo:wikiPageLength
10165
dbo:foundingYear
1929-01-01
dbo:numberOfEmployees
5700
dbo:industry
dbr:Pharmaceutical
dbo:keyPerson
dbr:Marc_de_Garidel
dbo:product
dbr:Rare_diseases dbr:Cough dbr:Pain dbr:Neuroscience dbr:Cognitive_disorder dbr:Oncology dbr:Gastroenterology
foaf:isPrimaryTopicOf
wikipedia-en:Ipsen
Subject Item
dbr:Irosustat
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Eure-et-Loir
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Exelixis
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Febuxostat
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:PAI_Partners
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Palovarotene
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:List_of_French_billionaires_by_net_worth
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:List_of_Georgetown_University_alumni
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Henri_Beaufour
dbo:wikiPageWikiLink
dbr:Ipsen
dbp:boards
dbr:Ipsen
dbo:board
dbr:Ipsen
Subject Item
dbr:Taspoglutide
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Tasquinimod
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Tercica
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Jeppesen_(surname)
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Margaret_A._Liu
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Abingworth_(company)
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Kaare_Christensen
dbo:wikiPageWikiLink
dbr:Ipsen
dbo:award
dbr:Ipsen
Subject Item
dbr:Lanreotide
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Laron_syndrome
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Dopexamine
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Setmelanotide
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Wrexham
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Somatostatin
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:PEGylation
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Pharmaceutical_industry_in_the_United_Kingdom
dbo:wikiPageWikiLink
dbr:Ipsen
Subject Item
dbr:Ipsen_Group
dbo:wikiPageWikiLink
dbr:Ipsen
dbo:wikiPageRedirects
dbr:Ipsen
Subject Item
dbr:Groupe_Ipsen
dbo:wikiPageWikiLink
dbr:Ipsen
dbo:wikiPageRedirects
dbr:Ipsen
Subject Item
wikipedia-en:Ipsen
foaf:primaryTopic
dbr:Ipsen